Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) Return on Sales (2016 - 2025)

Historic Return on Sales for Tandem Diabetes Care (TNDM) over the last 13 years, with Q3 2025 value amounting to 0.08%.

  • Tandem Diabetes Care's Return on Sales rose 100.0% to 0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.2%, marking a year-over-year decrease of 500.0%. This contributed to the annual value of 0.1% for FY2024, which is 2000.0% up from last year.
  • Latest data reveals that Tandem Diabetes Care reported Return on Sales of 0.08% as of Q3 2025, which was up 100.0% from 0.22% recorded in Q2 2025.
  • Tandem Diabetes Care's 5-year Return on Sales high stood at 0.05% for Q4 2021, and its period low was 0.73% during Q1 2023.
  • Its 5-year average for Return on Sales is 0.16%, with a median of 0.1% in 2024.
  • Per our database at Business Quant, Tandem Diabetes Care's Return on Sales tumbled by -6500bps in 2023 and then soared by 5100bps in 2024.
  • Quarter analysis of 5 years shows Tandem Diabetes Care's Return on Sales stood at 0.05% in 2021, then tumbled by -240bps to 0.07% in 2022, then crashed by -112bps to 0.15% in 2023, then soared by 102bps to 0.0% in 2024, then plummeted by -3194bps to 0.08% in 2025.
  • Its last three reported values are 0.08% in Q3 2025, 0.22% for Q2 2025, and 0.56% during Q1 2025.